-
Health Outcomes and Cost-effectiveness of Monoclonal SARS-CoV-2 Antibodies as Pre-exposure Prophylaxis
Popping, S., Nichols, B. E., Appelman, B., Biemond, J. J., Vergouwe, M., Rosendaal, F. R., van der Valk, M., de Bree, G. J., Wiersinga, W. J. & Birnie, E., 6 Jul 2023, In: JAMA network open. 6, 7, p. E2321985Research output: Contribution to journal › Article › Academic › peer-review
- All publications